Virtual Housecalls: Redesigning Pediatric Primary Care Adolescent Obesity Treatment
Virginia Commonwealth University · with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · NCT07246603
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 12–15 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 500
- US sites recruiting
- 1
- Study start
- August 25, 2026
- Record last updated
- August 26, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This pragmatic randomized clinical trial tests a novel intensive health behavior and lifestyle intervention, conducted via telehealth, to treat class I adolescent obesity in pediatric primary care. Results will inform scalable approaches that meet the recommended treatment dose and effectively treat obesity in this setting.
Being studied: Virtual Housecalls
Conditions: Class I Obesity; Pediatric Obesity
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Adolescent Inclusion Criteria
- English or Spanish-speaking
- 12-15 years of age
- Receiving care at a participating clinic
- Body Mass Index (BMI) ≥95% and \<120% of the 95%
- Access to a mobile device with a webcam that can receive texts
Parent Inclusion Criteria
- English or Spanish-speaking
- Primary legal guardian ≥18 years of age living with the adolescent
Exclusion Criteria
- conflicts that would inhibit the ability to participate in all aspects of the study as outlined in the study protocol
- family plans to move outside of the study area or plans to no longer be a patient at a participating clinic in the 12 month study period
- the primary care provider or PI determines that the study is not clinically or medically appropriate (e.g., significant psychiatric, cognitive, physical or developmental conditions that would impair their ability to complete assessments, participate in study sessions, or conduct physical activity) based on screening at study onset
- adolescent exhibits severe dietary restriction or compensatory behavior (e.g., vomiting, laxative abuse) based on screening at study onset and clinical interview by a study psychologist
- adolescent is currently pregnant/plans to become pregnant during study period
- adolescent is participating in another weight loss program, has had or plans to undergo weight loss surgery
- adolescent has a chronic medical condition(s) and/or uses medication that substantially impacts or interferes with growth, appetite, weight or physical activity participation
- adolescents taking anti-obesity medication are ineligible if they are not a stable dose for at least 3 months prior to study participation
Recruiting US locations
Children's Hospital of Richmond at VCU Healthy Lifestyles Center
Henrico, VA 23239
Site contact: Sarah M Farthing, MS · 804-527-4756 · sarah.malone@vcuhealth.org
Study contacts (from the official record)
- Sarah M Farthing, MS · 804-527-4756 · sarah.malone@vcuhealth.org
- Melanie K Bean, PhD · 804-527-4765 · melanie.bean@vcuhealth.org
Similar studies in Virginia
All weight loss studies in Virginia →- RecruitingHealthy volunteersPhase 1/Phase 2
Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates.
National Institute of Allergy and Infectious Diseases (NIAID)
- Location
- Falls Church, VA
- Eligibility basics
- Ages 0 mo–50
- RecruitingHealthy volunteersPhase 3
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
- Location
- Manassas, VA + 55 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 2
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
AbbVie
- Location
- Arlington, VA + 58 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
Novo Nordisk A/S
- Location
- Charlottesville, VA + 13 other US sites
- Eligibility basics
- Ages 10–18